Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

ClinicalTrials.gov ID: NCT04146896

Public ClinicalTrials.gov record NCT04146896. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT04146896
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aptinyx
Industry
Enrollment
228 participants

Conditions and interventions

Interventions

  • NYX-2925 50 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2019
Primary completion
Feb 22, 2022
Completion
Feb 22, 2022
Last update posted
Apr 27, 2023

2019 – 2022

United States locations

U.S. sites
35
U.S. states
12
U.S. cities
33
Facility City State ZIP Site status
Aptinyx Clinical Site Fresno California 93720
Aptinyx Clinical Site Irvine California 92612
Aptinyx Clinical Site Lomita California 90717
Aptinyx Clinical Site Los Angeles California 90048
Aptinyx Clinical Site Norco California 92860
Aptinyx Clinical Site Pomona California 91767
Aptinyx Clinical Site Santa Ana California 92705
Aptinyx Clinical Site Tustin California 92780
Aptinyx Clinical Site Brandon Florida 33511
Aptinyx Clinical Site Clearwater Florida 33765
Aptinyx Clinical Site Greenacres City Florida 33467
Aptinyx Clinical Site Miami Florida 33126
Aptinyx Clinical Site Miami Florida 33144
Aptinyx Clinical Site New Port Richey Florida 34655
Aptinyx Clinical Site Tampa Florida 33615
Aptinyx Clinical Site Tampa Florida 33634
Aptinyx Clinical Site Winter Haven Florida 33880
Aptinyx Clinical Site Winter Park Florida 32789
Aptinyx Clinical Site Decatur Georgia 30030
Aptinyx Clinical Site Marietta Georgia 30060
Aptinyx Clinical Site Blackfoot Idaho 83221
Aptinyx Clinical Site Flossmoor Illinois 60422
Aptinyx Clinical Site Rochester Michigan 48307
Aptinyx Clinical Site Hazelwood Missouri 63042
Aptinyx Clinical Site Las Vegas Nevada 89123
Aptinyx Clinical Site Brooklyn New York 11235
Aptinyx Clinical Site New York New York 10036
Aptinyx Clinical Site Rochester New York 14618
Aptinyx Clinical Site Greenville North Carolina 27834
Aptinyx Clinical Site Winston-Salem North Carolina 27103
Aptinyx Clinical Site Duncansville Pennsylvania 16635
Aptinyx Clinical Site Houston Texas 77030
Aptinyx Clinical Site Mesquite Texas 75149
Aptinyx Clinical Site Plano Texas 75024
Aptinyx Clinical Site San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04146896, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04146896 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →